PAK1IP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.388600E-01
Normal-vs-Stage2
6.682600E-01
Normal-vs-Stage3
2.579200E-01
Normal-vs-Stage4
2.981400E-01
Stage1-vs-Stage2
7.702800E-01
Stage1-vs-Stage3
5.961800E-01
Stage1-vs-Stage4
1.088830E-01
Stage2-vs-Stage3
3.989200E-01
Stage2-vs-Stage4
7.515800E-02
Stage3-vs-Stage4
6.092000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.853200E-01
Normal-vs-AfricanAmerican
8.627000E-01
Normal-vs-Asian
1.904580E-01
Caucasian-vs-AfricanAmerican
4.352400E-01
Caucasian-vs-Asian
1.789150E-01
AfricanAmerican-vs-Asian
7.200200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.795400E-01
Normal-vs-Female
7.808200E-01
Male-vs-Female
2.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.490240E-01
Normal-vs-Age(41-60Yrs)
8.451400E-01
Normal-vs-Age(61-80Yrs)
5.656600E-01
Normal-vs-Age(81-100Yrs)
9.373000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.568800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.843200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.085800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.426240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.989800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.089600E-01
Normal-vs-Daily Drinker
2.160600E-01
Normal-vs-Weekly Drinker
9.952600E-01
Normal-vs-Occasional Drinker
6.601200E-01
Normal-vs-Social Drinker
5.321200E-01
Non Drinker-vs-Daily Drinker
6.228400E-01
Non Drinker-vs-Weekly Drinker
2.099000E-01
Non Drinker-vs-Occasional Drinker
2.006000E-01
Non Drinker-vs-Social Drinker
4.296000E-01
Daily Drinker-vs-Weekly Drinker
1.348760E-01
Daily Drinker-vs-Occasional Drinker
9.596000E-02
Daily Drinker-vs-Social Drinker
2.405000E-01
Weekly Drinker-vs-Occasional Drinker
6.184600E-01
Weekly Drinker-vs-Social Drinker
4.672200E-01
Occasional Drinker-vs-Social Drinker
6.974200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.971600E-01
Normal-vs-Grade 2
8.901200E-01
Normal-vs-Grade 3
8.815200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.314100E-02
Grade 1-vs-Grade 3
8.989500E-02
Grade 1-vs-Grade 4
7.971600E-01
Grade 2-vs-Grade 3
8.182800E-01
Grade 2-vs-Grade 4
8.901200E-01
Grade 3-vs-Grade 4
8.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.110800E-01
Normal-vs-NonDiabetic
5.137000E-01
Diabetic-vs-NonDiabetic
9.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.174500E-02
Normal-vs-NoPancreatitis
5.540600E-01
Pancreatitis-vs-NoPancreatitis
1.661850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.706200E-01
Normal-vs-N1
7.259000E-01
N0-vs-N1
5.846600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.176600E-01
Normal-vs-TP53-NonMutant
5.327200E-01
TP53-Mutant-vs-TP53-NonMutant
2.614400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
